《浮生為卿歌》榮登蘋果遊戲暢銷榜前十
格隆匯4月7日丨根據七麥數據顯示:FriendTimes(6820.HK)於2019年12月底推出的女性向中國古風重磅大作《浮生為卿歌》,今日攀升至蘋果遊戲暢銷榜第十名。
FriendTimes,是一家以女性向遊戲為主的遊戲開發商、發行商及運營商,開創了女性向中國古風遊戲的品類。2019年度,集團的收益總額為16.891億元,較去年增加15.3%;經審核的年度純利為4.155億元,較去年增加23.4%;經調整EBITDA為4.787億元,較去年增加26.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.